REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Genemeds Inc. (Philippines)

Main Activities: Shoe Stores
Full name: Genemeds Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Genemeds Inc. is based in Philippines, with the head office in Not Disclosed. It operates in the Shoe Stores industry. The company was established on December 03, 2013. The latest financial highlights indicate a net sales revenue drop of 12.54% in 2024. There was a total growth of 11.34% in Genemeds Inc.’s total assets over the same period. In 2024, Genemeds Inc.’s net profit margin decreased by 0.14%.

Headquarters
Not Disclosed
Not Disclosed; Not Disclosed;

Contact Details: Purchase the Genemeds Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Genemeds Inc. report to view the information.
Incorporation Date:
December 03, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Genemeds Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-12.54%▼
Total operating revenue
-12.54%▼
Operating profit (EBIT)
-15.81%▼
EBITDA
-4.59%▼
Net Profit (Loss) for the Period
-15.81%▼
Total Assets
11.34%▲
Total Equity
13.53%▲
Operating Profit Margin (ROS)
-0.18%▼
Net Profit Margin
-0.14%▼
Return on Equity (ROE)
-5.22%▼
Quick Ratio
11.94%▲
Cash Ratio
16.53%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo